Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-08
2005-03-08
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S211070, C540S488000, C540S491000
Reexamination Certificate
active
06864250
ABSTRACT:
Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals
REFERENCES:
patent: 5441950 (1995-08-01), Collins et al.
patent: 5449675 (1995-09-01), Chandrakumar et al.
patent: 0 411 751 (1991-02-01), None
patent: WO9216524 (1992-10-01), None
patent: WO9615148 (1996-05-01), None
patent: WO9635713 (1996-11-01), None
patent: WO9700894 (1997-01-01), None
patent: WO9706803 (1997-02-01), None
patent: WO9722367 (1997-06-01), None
Funamizu Hidenori
Huang Ping
Ikegami Satoru
Inoguchi Kiyoshi
Ishiyama Nobuo
Coleman Brenda
Kaken Pharmaceutical Co. Ltd.
Molecular Research Institute
Nixon & Vanderhye P.C.
LandOfFree
N-acylated lipophilic amino acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-acylated lipophilic amino acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acylated lipophilic amino acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3436039